Rivaroxaban tied to higher bleeding rates vs. low-dose aspirin
In a systematic review and meta-analysis of trials of non-vitamin K oral anticoagulants vs. single antiplatelet therapy, rivaroxaban was associated with higher rates of major bleeding compared with low-dose aspirin, researchers reported.The same was not true for other non-vitamin K oral anticoagulants (NOACs).